Pongwut Danchaivijtr

6PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.

|Jan 08, 2025
Changing Landscape of Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma Treatment and Survival Trends in Thailand: A 13-Year Multicenter Retrospective Study of Patients.

Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Chanida Vinayanuwattikun

|Oct 29, 2024
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer.

Isamu Okamoto, Shoichi Kuyama, Nicolas Girard

|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.

Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim

|Feb 15, 2024
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy.

Jiraporn Setakornnukul, Janjira Petsuksiri, Panid Chaysiri

|Jun 28, 2023
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301.

Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang

Pageof 1

Frequent Collaborators

2 joint publications

Ji-Youn Han

2 joint publications

James Chih-Hsin Yang

2 joint publications

Shun Lu

2 joint publications

Nuttapong Ngamphaiboon